TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis, including profits, estimated losses, and the documents you will need for claim filing and settlement recovery.

Settlement Filing Deadlines

Company Amount Files Deadlinesort icon
Affymax - NASDAQ: AFFY $6,500,000 notice proof 12/27/2014
TXU Corporation - NYSE: TXU $590,500,000 notice proof 12/29/2014
Vestas -
PINK: VWDRY
PINK: VWSYF
OTC: VWDRY
OTC: VWSYF
$5,000,000 notice proof 12/29/2014
SunGard Data - NYSE: SDS $590,500,000 notice proof 12/29/2014
AMC Entertainmen... - NYSE: AMC $590,500,000 notice proof 12/29/2014
Aramark - NYSE: ARMK $590,500,000 notice proof 12/29/2014
Kinder Morgan - NYSE: KMI $590,500,000 notice proof 12/29/2014
HCA - NYSE: HCA $590,500,000 notice proof 12/29/2014
FreeScale Semico... - NYSE: FSL $590,500,000 notice proof 12/29/2014
Harrah's - NYSE: HET $590,500,000 notice proof 12/29/2014
LHC Group - NASDAQ: LHCG $7,850,000 notice proof 01/09/2015
AMAG Pharmaceuti... - NASDAQ: AMAG $3,750,000 notice proof 01/09/2015
Morgan Stanley - NYSE: MS $95,000,000 notice proof 01/15/2015
Nevsun Resources - NYSEAMEX: NSU $5,995,000 notice proof 01/22/2015
Bankrate - NASDAQ: RATE $18,000,000 notice proof 01/24/2015
Body Central - NASDAQ: BODY $3,425,000 notice proof 01/26/2015

Company or Ticker Search

Latest Aquisition

Cubist Pharmaceuticals Deal Case 12/17/2014

December 19, 2014 (Shareholders Foundation) - An investor, who currently holds shares of Cubist Pharmaceuticals Inc (NASDAQ:CBST), filed a lawsuit in effort to halt the proposed takeover of Cubist Pharmaceuticals Inc by Merck for $102 per share.

The plaintiff alleges that the defendants breached their fiduciary duties owed to NASDAQ:CBST stockholders by agreeing to sell Cubist Pharmaceuticals Inc too cheaply via an unfair process to...

here